xanthatin has been researched along with dehydroleucodine* in 2 studies
2 other study(ies) available for xanthatin and dehydroleucodine
Article | Year |
---|---|
Effect of a Cytoprotective Dose of Dehydroleucodine, Xanthatin, and 3-Benzyloxymethyl-5
The aim of this study was to determine whether the lactones dehydroleucodine, xanthatin and 3-benzyloxymethyl-5H-furan-2-one, would be effective in an animal model of gastric ulcer induced by mast cell activation. Rats were divided into ten groups. Treatments were repeated for four days. The degree of gastric erosion was assessed with a scoring system and histological preparations. Gastric mast cell morphology was analyzed by histological procedures. Serum serotonin levels were determined as markers of mast cell activation. Statistical analyses were done using ANOVA and Tukey-Kramer test. We demonstrated that the repeated administration of compound 48/80 results in extensive mucosal lesions in the gastric mucosa and that such lesions occurred in association with mast cell degranulation and a significant increase of serum serotonin. We showed that these lesions were prevented by dehydroleucodine, xanthatin, and 3-benzyloxymethyl-5H-furan-2-one and that this effect was similar to that obtained with sodium cromoglycate. In conclusion, the results of the present study indicate that the optimal gastric cytoprotective dose of dehydroleucodine, xanthatin, and 3-benzyloxymethyl-5 Topics: Animals; Cell Proliferation; Disease Models, Animal; Furans; Gastric Mucosa; Humans; Lactones; Mastocytosis; p-Methoxy-N-methylphenethylamine; Rats; Sesquiterpenes; Stomach Ulcer | 2021 |
Activation of human leukemic mast cell line LAD2 is modulated by dehydroleucodine and xanthatin.
The aim of the present study was to determine whether dehydroleucodine, xanthatin and 3-benzyloxymethyl-5H-furan-2-one inhibit the activation of human leukemic LAD2 mast cells induced by compound 48/80 or the calcium ionophore A23187. LAD2 cells were preincubated in the presence of test drugs and then challenged with the secretagogues. This study provides the first evidence in favor of the view that dehydroleucodine and xanthatin inhibit the degranulation of LAD2 cells, thus acting as human mast cell stabilizers. These molecules could be effective in the treatment of human diseases associated with inappropriate mast cell activation. Topics: beta-N-Acetylhexosaminidases; Calcimycin; Calcium Ionophores; Cell Degranulation; Cell Line, Tumor; Furans; Humans; Kinetics; Lactones; Leukemia, Mast-Cell; Mast Cells; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; p-Methoxy-N-methylphenethylamine; Sesquiterpenes | 2012 |